Cargando…
Improving Patient Outcomes While Reducing Empirical Treatment with Multiplex-Polymerase-Chain-Reaction/Pooled-Antibiotic-Susceptibility-Testing Assay for Complicated and Recurrent Urinary Tract Infections
This study compared rates of empirical-therapy use and negative patient outcomes between complicated and recurrent urinary tract infection (r/cUTI) cases diagnosed with a multiplex polymerase chain reaction or pooled antibiotic susceptibility testing (M-PCR/P-AST) vs. standard urine culture (SUC). S...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573050/ https://www.ncbi.nlm.nih.gov/pubmed/37835804 http://dx.doi.org/10.3390/diagnostics13193060 |
_version_ | 1785120375840964608 |
---|---|
author | Haley, Emery Luke, Natalie Korman, Howard Baunoch, David Wang, Dakun Zhao, Xinhua Mathur, Mohit |
author_facet | Haley, Emery Luke, Natalie Korman, Howard Baunoch, David Wang, Dakun Zhao, Xinhua Mathur, Mohit |
author_sort | Haley, Emery |
collection | PubMed |
description | This study compared rates of empirical-therapy use and negative patient outcomes between complicated and recurrent urinary tract infection (r/cUTI) cases diagnosed with a multiplex polymerase chain reaction or pooled antibiotic susceptibility testing (M-PCR/P-AST) vs. standard urine culture (SUC). Subjects were 577 symptomatic adults (n = 207 males and n = 370 females) presenting to urology/urogynecology clinics between 03/30/2022 and 05/24/2023. Treatment and outcomes were recorded by the clinician and patient surveys. The M-PCR/P-AST (n = 252) and SUC (n = 146) arms were compared after patient matching for confounding factors. The chi-square and Fisher’s exact tests were used to analyze demographics and clinical outcomes between study arms. Reduced empirical-treatment use (28.7% vs. 66.7%), lower composite negative events (34.5% vs. 46.6%, p = 0.018), and fewer individual negative outcomes of UTI-related medical provider visits and UTI-related visits for hospitalization/an urgent care center/an emergency room (p < 0.05) were observed in the M-PCR/P-AST arm compared with the SUC arm. A reduction in UTI symptom recurrence in patients ≥ 60 years old was observed in the M-PCR/P-AST arm (p < 0.05). Study results indicate that use of the M-PCR/P-AST test reduces empirical antibiotic treatment and negative patient outcomes in r/cUTI cases. |
format | Online Article Text |
id | pubmed-10573050 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-105730502023-10-14 Improving Patient Outcomes While Reducing Empirical Treatment with Multiplex-Polymerase-Chain-Reaction/Pooled-Antibiotic-Susceptibility-Testing Assay for Complicated and Recurrent Urinary Tract Infections Haley, Emery Luke, Natalie Korman, Howard Baunoch, David Wang, Dakun Zhao, Xinhua Mathur, Mohit Diagnostics (Basel) Article This study compared rates of empirical-therapy use and negative patient outcomes between complicated and recurrent urinary tract infection (r/cUTI) cases diagnosed with a multiplex polymerase chain reaction or pooled antibiotic susceptibility testing (M-PCR/P-AST) vs. standard urine culture (SUC). Subjects were 577 symptomatic adults (n = 207 males and n = 370 females) presenting to urology/urogynecology clinics between 03/30/2022 and 05/24/2023. Treatment and outcomes were recorded by the clinician and patient surveys. The M-PCR/P-AST (n = 252) and SUC (n = 146) arms were compared after patient matching for confounding factors. The chi-square and Fisher’s exact tests were used to analyze demographics and clinical outcomes between study arms. Reduced empirical-treatment use (28.7% vs. 66.7%), lower composite negative events (34.5% vs. 46.6%, p = 0.018), and fewer individual negative outcomes of UTI-related medical provider visits and UTI-related visits for hospitalization/an urgent care center/an emergency room (p < 0.05) were observed in the M-PCR/P-AST arm compared with the SUC arm. A reduction in UTI symptom recurrence in patients ≥ 60 years old was observed in the M-PCR/P-AST arm (p < 0.05). Study results indicate that use of the M-PCR/P-AST test reduces empirical antibiotic treatment and negative patient outcomes in r/cUTI cases. MDPI 2023-09-26 /pmc/articles/PMC10573050/ /pubmed/37835804 http://dx.doi.org/10.3390/diagnostics13193060 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Haley, Emery Luke, Natalie Korman, Howard Baunoch, David Wang, Dakun Zhao, Xinhua Mathur, Mohit Improving Patient Outcomes While Reducing Empirical Treatment with Multiplex-Polymerase-Chain-Reaction/Pooled-Antibiotic-Susceptibility-Testing Assay for Complicated and Recurrent Urinary Tract Infections |
title | Improving Patient Outcomes While Reducing Empirical Treatment with Multiplex-Polymerase-Chain-Reaction/Pooled-Antibiotic-Susceptibility-Testing Assay for Complicated and Recurrent Urinary Tract Infections |
title_full | Improving Patient Outcomes While Reducing Empirical Treatment with Multiplex-Polymerase-Chain-Reaction/Pooled-Antibiotic-Susceptibility-Testing Assay for Complicated and Recurrent Urinary Tract Infections |
title_fullStr | Improving Patient Outcomes While Reducing Empirical Treatment with Multiplex-Polymerase-Chain-Reaction/Pooled-Antibiotic-Susceptibility-Testing Assay for Complicated and Recurrent Urinary Tract Infections |
title_full_unstemmed | Improving Patient Outcomes While Reducing Empirical Treatment with Multiplex-Polymerase-Chain-Reaction/Pooled-Antibiotic-Susceptibility-Testing Assay for Complicated and Recurrent Urinary Tract Infections |
title_short | Improving Patient Outcomes While Reducing Empirical Treatment with Multiplex-Polymerase-Chain-Reaction/Pooled-Antibiotic-Susceptibility-Testing Assay for Complicated and Recurrent Urinary Tract Infections |
title_sort | improving patient outcomes while reducing empirical treatment with multiplex-polymerase-chain-reaction/pooled-antibiotic-susceptibility-testing assay for complicated and recurrent urinary tract infections |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573050/ https://www.ncbi.nlm.nih.gov/pubmed/37835804 http://dx.doi.org/10.3390/diagnostics13193060 |
work_keys_str_mv | AT haleyemery improvingpatientoutcomeswhilereducingempiricaltreatmentwithmultiplexpolymerasechainreactionpooledantibioticsusceptibilitytestingassayforcomplicatedandrecurrenturinarytractinfections AT lukenatalie improvingpatientoutcomeswhilereducingempiricaltreatmentwithmultiplexpolymerasechainreactionpooledantibioticsusceptibilitytestingassayforcomplicatedandrecurrenturinarytractinfections AT kormanhoward improvingpatientoutcomeswhilereducingempiricaltreatmentwithmultiplexpolymerasechainreactionpooledantibioticsusceptibilitytestingassayforcomplicatedandrecurrenturinarytractinfections AT baunochdavid improvingpatientoutcomeswhilereducingempiricaltreatmentwithmultiplexpolymerasechainreactionpooledantibioticsusceptibilitytestingassayforcomplicatedandrecurrenturinarytractinfections AT wangdakun improvingpatientoutcomeswhilereducingempiricaltreatmentwithmultiplexpolymerasechainreactionpooledantibioticsusceptibilitytestingassayforcomplicatedandrecurrenturinarytractinfections AT zhaoxinhua improvingpatientoutcomeswhilereducingempiricaltreatmentwithmultiplexpolymerasechainreactionpooledantibioticsusceptibilitytestingassayforcomplicatedandrecurrenturinarytractinfections AT mathurmohit improvingpatientoutcomeswhilereducingempiricaltreatmentwithmultiplexpolymerasechainreactionpooledantibioticsusceptibilitytestingassayforcomplicatedandrecurrenturinarytractinfections |